Form 4: Neogenomics Director Exercises Stock Options and Receives Shares
SEC Form 4 Filing
Director Michael Aaron Kelly exercised stock options and received shares of Neogenomics Inc. on August 10, 2024.
Summary
- On August 10, 2024, Michael Aaron Kelly, a director of Neogenomics Inc., executed transactions involving company stock.
- Kelly exercised restricted stock units, resulting in the acquisition of 11,336 shares of common stock.
- Following the transaction, Kelly directly owns 31,755 shares of Neogenomics Inc.
- Kelly also holds various stock options with different exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership.
Key Dates
| Date | Description |
|---|---|
| 05/28/2021 | Date of Stock Option (Right to Buy) with exercise price of $37.53 and expiration date of 05/28/2027 |
| 06/02/2022 | Date of Stock Option (Right to Buy) with exercise price of $40.9 and expiration date of 06/02/2028 |
| 06/10/2023 | Date of Stock Option (Right to Buy) with exercise price of $8.1 and expiration date of 06/10/2029 |
| 08/10/2024 | Date of transaction: Director exercised restricted stock units and acquired common stock. |
| 08/10/2024 | Date of Stock Option (Right to Buy) with exercise price of $14.82 and expiration date of 08/10/2033 |
| 06/01/2025 | Date of Stock Option (Right to Buy) with exercise price of $13.71 and expiration date of 06/01/2034 |
| 06/01/2025 | Date of Restricted Stock Unit |
| 05/28/2027 | Expiration date of Stock Option (Right to Buy) with exercise price of $37.53 |
| 06/02/2028 | Expiration date of Stock Option (Right to Buy) with exercise price of $40.9 |
| 06/10/2029 | Expiration date of Stock Option (Right to Buy) with exercise price of $8.1 |
| 08/10/2033 | Expiration date of Stock Option (Right to Buy) with exercise price of $14.82 |
| 06/01/2034 | Expiration date of Stock Option (Right to Buy) with exercise price of $13.71 |
| 08/13/2024 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.